Cefepime: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
|blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b> | |blackBoxWarningTitle=<b><span style="color:#FF0000;">TITLE</span></b> | ||
|blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | |blackBoxWarningBody=<i><span style="color:#FF0000;">Condition Name:</span></i> (Content) | ||
|fdaLIADAdult=[[file:Dosage Cefepime.png|none|700px]] | |||
|offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Cefepime in adult patients. | |offLabelAdultGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of Cefepime in adult patients. | ||
|offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Cefepime in adult patients. | |offLabelAdultNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of Cefepime in adult patients. | ||
Revision as of 20:43, 13 January 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alberto Plate [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Cefepime is a antibiotic (cephalosporin) that is FDA approved for the treatment of pneumonia, febrile neutropenia, uncomplicated UTI, uncomplicated skin infection and complicated intraabdominal infections. Common adverse reactions include rash, hypophosphatemia, diarrhea, Direct Coombs test positive, ALT/SGPT level raised, AST/SGOT level raised.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Cefepime in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Cefepime in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Cefepime FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Cefepime in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Cefepime in pediatric patients.
Contraindications
There is limited information regarding Cefepime Contraindications in the drug label.
Warnings
There is limited information regarding Cefepime Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Cefepime Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Cefepime Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Cefepime Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Cefepime in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Cefepime in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Cefepime during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Cefepime in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Cefepime in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Cefepime in geriatric settings.
Gender
There is no FDA guidance on the use of Cefepime with respect to specific gender populations.
Race
There is no FDA guidance on the use of Cefepime with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Cefepime in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Cefepime in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Cefepime in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Cefepime in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Cefepime Administration in the drug label.
Monitoring
There is limited information regarding Cefepime Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Cefepime and IV administrations.
Overdosage
There is limited information regarding Cefepime overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Cefepime Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Cefepime Mechanism of Action in the drug label.
Structure
There is limited information regarding Cefepime Structure in the drug label.
Pharmacodynamics
There is limited information regarding Cefepime Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Cefepime Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Cefepime Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Cefepime Clinical Studies in the drug label.
How Supplied
There is limited information regarding Cefepime How Supplied in the drug label.
Storage
There is limited information regarding Cefepime Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Cefepime |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Cefepime |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Cefepime Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Cefepime interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Cefepime Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Cefepime Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [4]
Overview
Cefepime is a fourth-generation cephalosporin antibiotic developed in 1994. Cefepime has an extended spectrum of activity against Gram-positive and Gram-negative bacteria, with greater activity against both Gram-negative and Gram-positive organisms than third-generation agents. Cefepime hydrochloride was first marketed in 1994 and is currently marketed under various trade names including Maxipime (Elan Pharma), Maxcef, Cepimax, Cepimex, and Axepim.
Category
Cephalosporin, Fourth-Generation
US Brand Names
MAXIPIME®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages